title: PET/CT is a cost-effective tool against cancer: synergy supersedes singularity.
authors.affiliation: Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Barbara Malene
authors.initials: BM
authors.lastname: Fischer
authors.affiliation: Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and Alvin J. Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA.
authors.forename: Barry A
authors.initials: BA
authors.lastname: Siegel
authors.affiliation: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Wolfgang A
authors.initials: WA
authors.lastname: Weber
authors.affiliation: SWAN Isotopen AG, c/o Inselspital, 3010, Bern, Switzerland.|European Industrial Association for Nuclear Medicine and Molecular Healthcare (AIPES eeig), Brussels, Belgium.
authors.forename: Konrade
authors.initials: K
authors.lastname: von Bremen
authors.affiliation: Center for Medical Physics and Biomedical Engineering, General Hospital Vienna, Medical University of Vienna, Waehringer Guertel 18-20/4 L, 1090, Vienna, Austria. thomas.beyer@meduniwien.ac.at.
authors.forename: Thomas
authors.initials: T
authors.lastname: Beyer
authors.affiliation: European Industrial Association for Nuclear Medicine and Molecular Healthcare (AIPES eeig), Brussels, Belgium.|Philips, Advanced Molecular Imaging, Guildford, GU2 8XG, UK.
authors.forename: Antonis
authors.initials: A
authors.lastname: Kalemis
mesh_terms: D003362:Cost-Benefit Analysis / Q000191:economics; D019317:Evidence-Based Medicine; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000191:economics*; D000072078:Positron Emission Tomography Computed Tomography / Q000191:economics* / Q000639:trends*; D019275:Radiopharmaceuticals / Q000191:economics*
chemical_list: D019275:Radiopharmaceuticals